Posted by Michael Wonder on 22 Feb 2018
A health economics approach to US value frameworks: serving the needs of decision-making
22 February 2018 - Value assessment is an integral component of decision making in health and is the focus of a themed section of Value in Health.
The Special Task Force Report considers a range of issues, both conceptual and practical, albeit limited to the US realities (more on this later), that arise in cost-effectiveness and cost-benefit studies of health care—particularly, though not only, in the context of designing or enlarging public health insurance schemes. Settling these is important but contentious.
As a start, this themed section includes four perspectives from key experts, representing payers, patients, academia, and the pharmaceutical industry. These perspectives have not been peer-reviewed by the journal in the conventional sense, and therefore should be considered as either personal or professional reflections on the report.
